IRIS
TARTAGLIONE, Immacolata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.080
NA - Nord America 1.345
AS - Asia 1.199
SA - Sud America 214
AF - Africa 28
OC - Oceania 2
Totale 5.868
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.130
US - Stati Uniti d'America 1.316
SG - Singapore 439
IE - Irlanda 298
IT - Italia 272
CN - Cina 251
HK - Hong Kong 207
BR - Brasile 176
VN - Vietnam 126
DE - Germania 105
GB - Regno Unito 86
KR - Corea 51
JP - Giappone 32
IN - India 31
UA - Ucraina 30
FR - Francia 28
GR - Grecia 22
FI - Finlandia 20
AR - Argentina 17
AT - Austria 15
SE - Svezia 15
BD - Bangladesh 13
CA - Canada 13
NL - Olanda 13
PK - Pakistan 13
MX - Messico 11
BE - Belgio 10
ZA - Sudafrica 10
TR - Turchia 9
CH - Svizzera 8
ES - Italia 7
VE - Venezuela 7
ID - Indonesia 6
EC - Ecuador 5
CO - Colombia 4
DZ - Algeria 4
IL - Israele 4
CL - Cile 3
MA - Marocco 3
PL - Polonia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AU - Australia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IQ - Iraq 2
JO - Giordania 2
LT - Lituania 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
TW - Taiwan 1
Totale 5.868
Salva come PNG Salva come JPEG
Città #
Moscow 785
Dublin 289
Hong Kong 204
Singapore 203
San Jose 191
Santa Clara 173
Chandler 122
Ashburn 78
Jacksonville 66
Seoul 50
Beijing 49
New York 45
Caserta 43
Princeton 38
Roxbury 38
Ann Arbor 36
Hanoi 35
Ho Chi Minh City 35
Bremen 33
Hefei 33
Naples 33
Munich 32
Dallas 24
Grumo Nevano 21
Cambridge 20
Ercolano 20
Bengaluru 19
Medford 19
Los Angeles 17
The Dalles 17
Wilmington 17
Woodbridge 17
Des Moines 13
São Paulo 13
Nuremberg 12
Da Nang 11
Helsinki 11
Nanjing 11
Boardman 10
Brussels 10
Milan 10
Rome 10
Vienna 10
London 9
Amsterdam 8
Johannesburg 8
Napoli 8
Pozzuoli 8
Falkenstein 7
Haiphong 7
Redwood City 7
Belo Horizonte 6
Brooklyn 6
Montreal 6
Nanchang 6
Orem 6
Shanghai 6
Turku 6
Atlanta 5
Biên Hòa 5
Hillsboro 5
Orlando 5
Rio de Janeiro 5
Bologna 4
Brasília 4
Buffalo 4
Campinas 4
Curitiba 4
Fairfield 4
Lahore 4
Salvador 4
San Mateo 4
Stockholm 4
Taizhou 4
Tokyo 4
Afragola 3
Aversa 3
Boston 3
Chicago 3
Guangzhou 3
Istanbul 3
Manchester 3
Mexico City 3
Phoenix 3
Poplar 3
Quito 3
Ribeirão Preto 3
Shenyang 3
Takoma Park 3
Tashkent 3
Tel Aviv 3
Thái Nguyên 3
Tianjin 3
Toronto 3
Abidjan 2
Acalanes Ridge 2
Ankara 2
Araraquara 2
Asunción 2
Bandung 2
Totale 3.169
Salva come PNG Salva come JPEG
Nome #
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 219
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 213
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 174
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 173
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 171
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 167
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 157
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 157
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 152
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy 149
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 148
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 145
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 143
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 141
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 141
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 138
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 138
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 137
Brain perfusion changes in beta-thalassemia 132
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 131
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 130
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 125
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 125
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS) 119
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia 117
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 113
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 108
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 105
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 104
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with beta-thalassemia. 103
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 102
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. 101
Hearing loss in beta-thalassaemia: An Italian multicentre case-control study 100
Hearing loss in beta-thalassemia: Systematic review 98
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 96
Cognitive impairment in hereditary spherocytosis 94
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: Phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study 92
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana 91
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 90
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds 87
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies 87
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 80
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 79
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited 76
Pregnancy and childbirth in women with thalassemia: past and present 76
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia 75
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 75
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 72
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias 69
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises 60
Disease Burden in Transfusion-Dependent β-Thalassemia (TDT) Patients and Caregivers in Italy: Results of a Cross-Sectional Descriptive Online Survey 12
Cerebrovascular involvement in hereditary spherocytosis: observational cohort and case-control MRI study 6
International variations in body mass index within the CASiRe global cohort of sickle cell disease patients 4
Identification of Novel Mutations in Patients Affected by Gaucher Disease 4
Totale 6.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022279 6 4 5 4 61 10 31 25 18 7 20 88
2022/2023578 55 22 22 28 57 54 3 19 287 7 13 11
2023/2024235 19 7 18 14 63 47 4 5 5 0 19 34
2024/2025878 2 7 5 20 131 102 166 86 131 81 87 60
2025/20263.546 128 152 176 172 345 1.948 188 130 119 97 74 17
Totale 6.001